Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Winn

Showing results (81-90 of 175) with videos related to

Pageof 18
Sort By:
Oncogene|October 19, 2002
gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growthRobert A Winn, Roy M Bremnes, Lynne Bemis, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Project COALESCE-An Example of Academic Institutions as Conveners of Community-Clinic Partnerships to Improve Cancer Screening AccessKatherine Y Tossas, Savannah Reitzel, Katelyn Schifano, et al.
Molecular Cancer Research : MCR|May 27, 2010
Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancerMeredith A Tennis, Michelle M Van Scoyk, Scott V Freeman, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
In vitro methylation assay to study protein arginine methylationRama Kamesh Bikkavilli, Sreedevi Avasarala, Michelle Van Scoyk, et al.
Molecular Pharmacology|October 23, 2002
Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growthMarilee Wick, Greg Hurteau, Christina Dessev, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 12, 2022
Detection and Transmission of <i>Proteus mirabilis</i> in Immunodeficient MiceRebecca K Tierce, Adrienne A Winn, Theresa M Albers, et al.
Pharmacogenomics and Personalized Medicine|May 22, 2013
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategiesMarybeth Sechler, Amber D Cizmic, Sreedevi Avasarala, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Community-Academic Partnerships: Approaches to EngagementLailea Noel, Farya Phillips, Katherine Tossas-Milligan, et al.
Cancer Causes & Control : CCC|August 22, 2017
A geographic information system-based method for estimating cancer rates in non-census defined geographical areasVincent L Freeman, Emma E Boylan, Oksana Pugach, et al.
Frontiers in Oncology|March 28, 2019
Lung Cancer Screening and Epigenetics in African Americans: The Role of the Socioecological FrameworkKarriem Sadot Watson, Alicia Hulbert, Vida Henderson, et al.
Pageof 18

Showing results (81-90 of 175) with videos related to

Sort By:
Pageof 18
Oncogene|October 19, 2002
gamma-Catenin expression is reduced or absent in a subset of human lung cancers and re-expression inhibits transformed cell growthRobert A Winn, Roy M Bremnes, Lynne Bemis, et al.
International Journal of Environmental Research and Public Health|January 21, 2022
Project COALESCE-An Example of Academic Institutions as Conveners of Community-Clinic Partnerships to Improve Cancer Screening AccessKatherine Y Tossas, Savannah Reitzel, Katelyn Schifano, et al.
Molecular Cancer Research : MCR|May 27, 2010
Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancerMeredith A Tennis, Michelle M Van Scoyk, Scott V Freeman, et al.
Journal of Visualized Experiments : Jove|October 29, 2014
In vitro methylation assay to study protein arginine methylationRama Kamesh Bikkavilli, Sreedevi Avasarala, Michelle Van Scoyk, et al.
Molecular Pharmacology|October 23, 2002
Peroxisome proliferator-activated receptor-gamma is a target of nonsteroidal anti-inflammatory drugs mediating cyclooxygenase-independent inhibition of lung cancer cell growthMarilee Wick, Greg Hurteau, Christina Dessev, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|March 12, 2022
Detection and Transmission of <i>Proteus mirabilis</i> in Immunodeficient MiceRebecca K Tierce, Adrienne A Winn, Theresa M Albers, et al.
Pharmacogenomics and Personalized Medicine|May 22, 2013
Non-small-cell lung cancer: molecular targeted therapy and personalized medicine - drug resistance, mechanisms, and strategiesMarybeth Sechler, Amber D Cizmic, Sreedevi Avasarala, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Community-Academic Partnerships: Approaches to EngagementLailea Noel, Farya Phillips, Katherine Tossas-Milligan, et al.
Cancer Causes & Control : CCC|August 22, 2017
A geographic information system-based method for estimating cancer rates in non-census defined geographical areasVincent L Freeman, Emma E Boylan, Oksana Pugach, et al.
Frontiers in Oncology|March 28, 2019
Lung Cancer Screening and Epigenetics in African Americans: The Role of the Socioecological FrameworkKarriem Sadot Watson, Alicia Hulbert, Vida Henderson, et al.
Pageof 18